Last reviewed · How we verify

NCT06174311

The Effectiveness of Cognitive Bias Modification on Intolerance of Uncertainty

Completed NA Last updated 23 January 2026
What this trial tests

NA trial testing Active Cognitive Bias Modification in Intolerance to Uncertainty in 90 participants. Completed in 20 June 2024.

Timeline
23 November 2023
Primary endpoint
20 March 2024
20 June 2024

Quick facts

Lead sponsorIzmir University of Economics
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposeprevention
Enrollment90
Start date23 November 2023
Primary completion20 March 2024
Estimated completion20 June 2024
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Izmir University of Economics

Who can join

Adults 18 to 40, any sex, with Intolerance to Uncertainty. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The current study aims to reduce the intolerance of uncertainty levels with an internet-based cognitive bias modification intervention in young adults with high levels of intolerance to uncertainty aged between 18 and 40. Furthermore, it aims to examine the intervention's effectiveness on their intolerance to uncertainty, positive and negative emotions, depression and anxiety symptoms, and repetitive thinking.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Izmir University of Economics trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06174311.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing